Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Enokida

Showing results (131-140 of 177) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinomaJulia E Breault, Hiroaki Shiina, Mikio Igawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancerKen Kawamoto, Steven T Okino, Robert F Place, et al.
International Journal of Cancer|April 1, 2005
Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancerHideki Enokida, Hiroaki Shiina, Shinji Urakami, et al.
International Journal of Clinical Oncology|April 2, 2020
A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tablesMakito Miyake, Hideyasu Matsuyama, Satoshi Teramukai, et al.
BMC Cancer|October 30, 2024
Development of a novel treatment based on PKMYT1 inhibition for cisplatin-resistant bladder cancer with miR-424-5p-dependent cyclin E1 amplificationWataru Fukumoto, Shunsuke Okamura, Motoki Tamai, et al.
Biochemical and Biophysical Research Communications|November 16, 2004
Inactivation of the hMSH3 mismatch repair gene in bladder cancerToshifumi Kawakami, Hiroaki Shiina, Mikio Igawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2021
Editor's Note: Epigenetic Modifications of <i>RASSF1A</i> Gene through Chromatin Remodeling in Prostate CancerKen Kawamoto, Steven T Okino, Robert F Place, et al.
Molecular Oncology|June 14, 2024
Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine- and cisplatin-resistant modelsIchiro Kawahara, Hirofumi Yoshino, Wataru Fukumoto, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 10, 2026
Impact of radium-223 on bone imaging and biochemical markers with and without bone-modifying agents in bone-metastatic castration-resistant prostate cancer: results from the kyucog-1901 studyMasaki Shiota, Hideki Enokida, Yoji Murakami, et al.
Plos One|August 29, 2012
Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151Takeshi Chiyomaru, Soichiro Yamamura, Mohd Saif Zaman, et al.
Pageof 18

Showing results (131-140 of 177) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinomaJulia E Breault, Hiroaki Shiina, Mikio Igawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancerKen Kawamoto, Steven T Okino, Robert F Place, et al.
International Journal of Cancer|April 1, 2005
Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancerHideki Enokida, Hiroaki Shiina, Shinji Urakami, et al.
International Journal of Clinical Oncology|April 2, 2020
A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tablesMakito Miyake, Hideyasu Matsuyama, Satoshi Teramukai, et al.
BMC Cancer|October 30, 2024
Development of a novel treatment based on PKMYT1 inhibition for cisplatin-resistant bladder cancer with miR-424-5p-dependent cyclin E1 amplificationWataru Fukumoto, Shunsuke Okamura, Motoki Tamai, et al.
Biochemical and Biophysical Research Communications|November 16, 2004
Inactivation of the hMSH3 mismatch repair gene in bladder cancerToshifumi Kawakami, Hiroaki Shiina, Mikio Igawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2021
Editor's Note: Epigenetic Modifications of <i>RASSF1A</i> Gene through Chromatin Remodeling in Prostate CancerKen Kawamoto, Steven T Okino, Robert F Place, et al.
Molecular Oncology|June 14, 2024
Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine- and cisplatin-resistant modelsIchiro Kawahara, Hirofumi Yoshino, Wataru Fukumoto, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 10, 2026
Impact of radium-223 on bone imaging and biochemical markers with and without bone-modifying agents in bone-metastatic castration-resistant prostate cancer: results from the kyucog-1901 studyMasaki Shiota, Hideki Enokida, Yoji Murakami, et al.
Plos One|August 29, 2012
Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151Takeshi Chiyomaru, Soichiro Yamamura, Mohd Saif Zaman, et al.
Pageof 18